Globeflex Capital L P Sells 3,348 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Globeflex Capital L P trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 57.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,447 shares of the healthcare conglomerate’s stock after selling 3,348 shares during the quarter. Globeflex Capital L P’s holdings in UnitedHealth Group were worth $1,238,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $30,000. Promus Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $32,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group in the 3rd quarter worth approximately $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $40,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $488.52 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a market capitalization of $446.85 billion, a P/E ratio of 31.52, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company’s 50-day moving average is $511.36 and its 200 day moving average is $550.33.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.83 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.72%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on UNH shares. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Piper Sandler cut their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, Stephens boosted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.